SCHEMBL6246793

SCHEMBL6246793

CC1C(=O)N(CCCN2CCN(c3ccccc3OC3CCCC3)CC2)C(=O)C1NC1CC1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 10/20 0.51
HTR7 P34969 4/20 0.51
DRD2 P14416 2/20 0.48
HTR2A P28223 1/20 0.48
HTR6 P50406 1/20 0.48
DRD3 P35462 1/20 0.46
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5421867 0.97 HTR1A (0.51) HTR1AHTR7DRD2HTR2AHTR6
Hydrochloric Acid SCHEMBL5422079 0.96 HTR1A (0.50) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL5424353 0.91 HTR1A (0.53) HTR1AHTR7DRD2HTR2AHTR6
Hydrochloric Acid SCHEMBL5418538 0.90 HTR1A (0.52) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL5433120 0.90 HTR1A (0.45) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL5424281 0.90 HTR1A (0.56) HTR1AHTR7DRD2HTR2AHTR6
SCHEMBL5424943 0.89 HTR1A (0.51) HTR1AHTR7DRD2HTR2AHTR6
Hydrochloric Acid SCHEMBL5424727 0.89 HTR1A (0.45) HTR1AHTR7DRD2HTR2AHTR6
Hydrochloric Acid SCHEMBL5421894 0.89 HTR1A (0.55) HTR1AHTR7DRD2HTR2AHTR6
Hydrochloric Acid SCHEMBL5420356 0.88 HTR1A (0.51) HTR1AHTR7DRD2HTR2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037281-A1 1-ALKYLPIPERAZINYL-PYRROLIDIN-2, 5-DIONE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONIST RANBAXY LABORATORIES LIMITED (IN) 2005-04-28 WO disclosed